F19.131 Other psychoactive substance abuse with withdrawal delirium

Name of the Condition

• Other Psychoactive Substance Abuse with Withdrawal Delirium
• ICD-10 Code: F19.131

Summary

This condition involves the abuse of psychoactive substances not classified in other specific categories, accompanied by withdrawal delirium. Withdrawal delirium occurs when substance use is reduced or stopped, leading to a disturbance in consciousness with reduced ability to focus, sustain, or shift attention, along with changes in cognition (e.g., memory deficit, disorientation, language disturbance). The delirium is a severe manifestation of withdrawal and is recurrent despite negative consequences.

Causes

The causes include recreational or non-medical use of psychoactive substances, leading to physiological dependence through repeated use. Withdrawal delirium arises when substance use is abruptly reduced or discontinued, triggering a hyperactive state of the central nervous system. The specific substances involved are not categorized under more detailed codes, but the condition reflects a severe withdrawal reaction.

Risk Factors

• History of substance use disorders
• Prior episodes of withdrawal delirium
• Concurrent medical or neurological conditions
• High-dose or prolonged substance use
• Abrupt cessation of substance use

Symptoms

• Disturbance in consciousness (e.g., reduced alertness, fluctuating course)
• Cognitive changes (e.g., disorientation, memory impairment, perceptual disturbances)
• Psychomotor agitation or retardation
• Sleep-wake cycle disturbance
• Onset during or shortly after substance withdrawal

Diagnosis

Diagnosis requires a clinical assessment by a healthcare professional, including a detailed history of substance use and its impact on daily functioning. The diagnosis is based on the presence of withdrawal delirium symptoms, which must be temporally related to substance cessation or reduction. No specific lab tests confirm the condition, but substance screening may support the evaluation.

Treatment Options

Treatment focuses on managing withdrawal symptoms and addressing delirium. This may include supportive care (e.g., hydration, electrolyte correction), pharmacological interventions to stabilize the central nervous system, and monitoring for complications. Long-term management involves addressing the underlying substance use disorder through behavioral or pharmacological therapies.

Prognosis and Follow-Up

Prognosis depends on the severity of delirium, underlying health status, and promptness of treatment. With appropriate care, delirium may resolve within days to weeks, but residual cognitive impairment can occur. Follow-up includes monitoring for recurrence of substance use and ongoing management of the substance use disorder to prevent future withdrawal episodes.

Complications

• Seizures
• Respiratory depression
• Cardiovascular instability
• Prolonged cognitive impairment
• Increased risk of injury due to confusion or agitation

Lifestyle & Prevention

Prevention involves gradual tapering of substance use under medical supervision to avoid abrupt withdrawal. Lifestyle modifications may include avoiding triggers, engaging in supportive therapies, and maintaining regular follow-up with healthcare providers. Education on the risks of substance abuse and withdrawal is critical for long-term prevention.

When to Seek Professional Help

Seek immediate medical attention if symptoms of withdrawal delirium occur, including confusion, agitation, or altered consciousness. Prompt evaluation is necessary to prevent life-threatening complications. Ongoing professional help is recommended for managing the underlying substance use disorder.

Tips for Medical Coders

Document the presence of withdrawal delirium, including its temporal relationship to substance cessation or reduction. Ensure clinical notes specify the substance involved (if known) and the severity of delirium symptoms. Code F19.131 is appropriate when delirium is the primary manifestation of withdrawal from other psychoactive substances.